Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions

Psychopharmacology

Volumn 161, Issue 1, 2002, Pages 100-106

  Zhang, Kehong ^a,b   Davids, Eugen ^a,b   Tarazi, Frank I ^a,b   Baldessarini, Ross J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

6 Hydroxydopamine; Antagonist; Attention deficit hyperactivity disorder (ADHD); D4 receptor; Dopamine; Motor activity

Indexed keywords

1 (1,4 BENZODIOXAN 6 YL) 4 (2 INDANYLMETHYL)PIPERAZINE; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 7 (4 FLUOROPHENOXYMETHYL) 2 (5 FLUORO 2 PYRIMIDINYL) 2,3,4,6,7,8,9,9A OCTAHYDROPYRIDO[1,2 A]PYRAZINE; DESIPRAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; KETANSERIN; N (1 BENZYL 4 PIPERIDINYL) N (3 ISOPROPOXY 2 PYRIDINYL) N METHYLAMINE; OXIDOPAMINE; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C ANTAGONIST; DOPAMINE 2 RECEPTOR; DRD4 PROTEIN, RAT; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG SELECTIVITY; HYPERACTIVITY; INFRARED RADIATION; LOCOMOTION; MALE; NEUROPROTECTION; NEWBORN; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; RAT; SEDATION; ANIMAL; DRUG ANTAGONISM; MOTOR ACTIVITY; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; KETANSERIN; MALE; MOTOR ACTIVITY; OXIDOPAMINE; RATS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; RECEPTORS, SEROTONIN;

EID: 0036011102     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1018-1     Document Type: Article

References (49)

1. Neonatal 6-hydroxydopamine-induced dopamine depletions: Motor activity and performance in maze learning
2. 4 dopamine receptor protein in the CNS using anti-receptor antisera
3. 4 forms of the human and rat genes
4. DRD4 gene and susceptibility to attention deficit hyperactivity disorder
5. Drugs and the treatment of psychiatric disorders: Psychosis and mania
6. Frontal lobe functions in attention deficit disorder with and without hyperactivity: A review and research report
7. 4 dopamine receptor gene and measures of novelty-seeking
8. 4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests
9. 6-Hydroxydopamine lesion of the rat prefrontal cortex increase locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze
10. 4 dopamine receptor agonists and antagonists
11. 4 receptor gene shows no evidence of association with schizophrenia
12. 4 dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain
13. Ultrastructural analysis of serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxy-dopamine
14. 4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking
15. The interface of genetics, neuroimaging, and neurochemistry in attention-deficit hyperactivity disorder
16. 4 gene 7-repeat allele and attention deficit hyperactivity disorder
17. 2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex
18. 4.4 receptor
19. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine
20. 4 acutely psychotic inpatients with schizophrenia
21. 3H]β-CIT: A radioligand for dopamine transporter in rat brain tissue
22. 4 is associated with attention deficit hyperactivity disorder
23. 4 (DRD4) gene
24. Effects of amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment
25. S 18126 ({2-[4-(2,3-dihydro-benzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl}), a potent, selective and competitive antagonist at dopamine D4 receptors: An in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2,3b]pyridine) and raclopride
26. 4 GABAergic neurons of the primate brain
27. Molecular biology of dopamine receptors
28. 4.4 receptors: Actions of antiparkisonian and antipsychotic agents
29. 4 receptor
30. 1C receptors
31. 4 receptor antagonist
32. 4 receptor
33. 4 gene is not associated with major psychosis
34. Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine
35. Selective brain dopamine depletion in developing rats: An experimental model of minimal brain dysfunction
36. Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats
37. 4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD)
38. Active and passive avoidance learning in rats neonatally treated with intraventricular 6-hydroxydopamine
39. 4 receptors: Significance for molecular psychiatry at the millennium
40. 4-like receptors
41. 2A antagonist fananserin in the treatment of schizophrenia
42. Cloning of a human dopamine D4 receptor gene with high affinity for the antipsychotic clozapine
43. 4 receptor variants in the human population
44. Contrasting effects of excitotoxic lesions of the prefrontal cortex on the behavioral response to D-amphetamine and presynaptic and postsynaptic measures of striatal dopamine function in monkeys
45. 4 receptor binding in rat caudateputamen
46. 4 receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats
47. Plasticity of dopamine D4 receptors in rat forebrain: Temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning